Liminatus Pharma, Inc. - LIMN
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 15
Latest filed: Jul 30, 2026
| Form | Count |
|---|---|
| 8-K | 9 |
| SCHEDULE 13G | 2 |
| 4 | 2 |
| SCHEDULE 13D/A | 1 |
| SCHEDULE 13G/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Jul 30, 2026 | 8-K | Jul 29, 2026 | 0001104659-26-088380 | View |
| Jul 24, 2026 | 8-K | Jul 20, 2026 | 0001104659-26-086674 | View |
| Jul 22, 2026 | SCHEDULE 13G | — | 0001104659-26-085882 | View |
| Jul 14, 2026 | SCHEDULE 13D/A | — | 0001104659-26-083585 | View |
| Jul 14, 2026 | 4 | Jul 02, 2026 | 0001104659-26-083588 | View |
| Jul 06, 2026 | SCHEDULE 13G/A | — | 0001104659-26-080802 | View |
| Jul 06, 2026 | 4 | Jun 24, 2026 | 0001104659-26-080806 | View |
| Jul 06, 2026 | 8-K | Jun 29, 2026 | 0001104659-26-080613 | View |
| Jun 03, 2026 | 8-K | Jun 03, 2026 | 0001104659-26-070173 | View |
| May 27, 2026 | 8-K | May 20, 2026 | 0001104659-26-066974 | View |
| May 20, 2026 | 8-K | May 17, 2026 | 0001104659-26-064585 | View |
| Mar 04, 2026 | 8-K | Feb 27, 2026 | 0001104659-26-023467 | View |
| Feb 20, 2026 | SCHEDULE 13G | — | 0001213900-26-018820 | View |
| Feb 18, 2026 | 8-K | Feb 17, 2026 | 0001104659-26-017134 | View |
| Feb 09, 2026 | 8-K | Feb 06, 2026 | 0001104659-26-012016 | View |